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Abstract
Background: The function of the prion protein, involved in the so-called prion diseases, remains a subject of
intense debate and the possibility that it works as a pleiotropic protein through the interaction with multiple
membrane proteins is somehow supported by recent reports. Therefore, the use of proteomic and bioinformatics
combined to uncover cellular processes occurring together with changes in the expression of the prion protein
may provide further insight into the putative pleiotropic role of the prion protein.
Results: This study assessed the membrane-enriched proteome changes accompanying alterations in the expression
of the prion protein. A 2D-DIGE approach was applied to two cell lines after prefractionation towards the membrane
protein subset: an embryonic stem cell line and the PK1 subline of neuroblastoma cells which efficiently propagates
prion infection. Several proteins were differentially abundant with the increased expression of the prion protein during
neural differentiation of embryonic stem cells and with the knockdown of the prion protein in PK1 cells. The identity of
around 20% of the differentially abundant proteins was obtained by tandem MS. The catalytic subunit A of succinate
dehydrogenase, a key enzyme for the aerobic energy metabolism and redox homeostasis, showed a similar abundance
trend as the prion protein in both proteomic experiments. A gene ontology analysis revealed “myelin sheath”,
“organelle membrane” and “focal adhesion” associated proteins as the main cellular components, and “protein folding”
and “ATPase activity” as the biological processes enriched in the first set of differentially abundant proteins. The known
interactome of these differentially abundant proteins was customized to reveal four interactors with the prion protein,
including two heat shock proteins and a protein disulfide isomerase.
Conclusions: Overall, our study shows that expression of the prion protein occurs concomitantly with changes in
chaperone activity and cell-redox homeostasis, emphasizing the functional link between these cellular processes and
the prion protein.
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Background
Prion diseases, such as Creutzfeldt-Jakob disease (CJD)
in humans, bovine spongiform encephalopathy (BSE) in
cow and scrapie in sheep are fatal neurodegenerative
protein misfolding diseases. In humans, the sporadic
form of CJD accounts for the majority of cases [1].
Inherited prion disease occurs due to germline muta-
tions in PRNP that predispose individuals to CJD,
Gerstmann-Straussler-Scheinker Disease or Fatal Familial
Insomnia. The acquired prion diseases include accidental
inoculation during medical procedures (iatrogenic CJD) or
exposure to food products contaminated with BSE (variant
CJD) [2]. The prion protein (PrP) involved in these dis-
eases is a conserved ubiquitously expressed glycoprotein
most abundant in the central nervous system. The mature
form is anchored to the cell membrane by a
glycosylphosphatidylinositol (GPI) group. It has an alpha
helix-rich C-terminal globular domain, containing two
asparagine-linked glycosylation sites, an intramolecular di-
sulphide bond, a hydrophobic central region and an un-
structured N-terminal domain, containing five repeats of a
copper-binding octapeptide [3]. The disease associated
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isoform, or scrapie prion protein (PrPSc to distinguish
from the cellular form PrPC), has higher beta sheet con-
tent, propensity to aggregate and it is able to replicate by
binding to cellular prion protein and refolding it into the
scrapie conformation [2, 4].
The first results obtained with two distinct PrP null
mouse strains suggested that either PrP is unnecessary
for normal development or its absence is somehow com-
pensated [5, 6]. Later constructs used to knockout PrP
have shown a neurodegenerative phenotype, caused by
ectopic expression of its homologue doppel [7–9]. How-
ever, the clearest phenotype of PrP knockout mice is re-
sistance to prion infection and inability to replicate
prions [10, 11]. Based on the mild phenotypic traits in
these knockouts and on cell culture studies, PrP has
been assigned roles in many biological processes includ-
ing myelin maintenance, copper and zinc transport, cal-
cium homeostasis, as well as neuroprotective activities
against several toxic insults, such as oxidative and exci-
totoxic damage [11–13]. PrP was also shown to promote
the self-renewal and to regulate the proliferation of
haematopoietic stem cells, human embryonic stem (ES)
cells and neural precursors [14–17]. Additionally, treat-
ment of embryonic hippocampal neurons with recom-
binant PrP enhanced neurite outgrowth and survival
[18]. Altogether, these reports suggest that PrP plays a
role as a switch from uncommitted multipotent precur-
sors towards the generation of neurons [19]. To confirm
this, it was shown recently that silencing PrP suppressed
differentiation of human ES cells towards ectodermal
lineages indicating that expression of PrP guides differ-
entiation into neuron-, oligodendrocyte-, and astrocyte-
committed lineages [20].
Structurally, PrP does not span the membrane and
cannot transduce signals into the cytosol, but due to its
binding partners it has been proposed to be involved in
the assembly of signalling complexes [4]. Accordingly, it
is pivotal the identification of additional proteins in-
volved in the cellular functions of PrP and, eventually, in
the protein misfolding replicative mechanism that leads
to infection. Therefore, this study focused on assessing
the membrane-associated proteome changes occurring
together with alterations in the expression of PrP, aiming
at finding potentially new interacting proteins. Two cel-
lular systems with opposite changes in the expression of
PrP were used: in one the expression of PrP increased
during neural differentiation of ES cells and, in the other
one, we used a neuroblastoma cell line knockdown for
PrP. The neuroblastoma cell line PK1 was selected for
its ability to replicate PrPSc and for the availability of a
counterpart PrP knockdown cell line [21]. The quantita-
tive 2D-DIGE identified 25 differentially abundant pro-
teins during neural differentiation of ES cells, most of
them belonging to the heat shock protein (HSPs) and
the protein disulfide isomerase (PDIs) families. For
neuroblastoma PK1 cells knockdown for PrP (PK1-KD),
6 differentially abundant proteins were identified. In
order to obtain further insight into the differentially
abundant protein functions, a Gene Ontology (GO) ana-
lysis was undertaken, together with the comprehensive
assembly of an individual interactome for each differen-
tially abundant protein set. Interestingly, succinate de-
hydrogenase complex, subunit A, a key enzyme for the
energy metabolism that catalyzes the oxidation of suc-
cinate to fumarate and that is essential to prevent oxida-
tive stress [22], correlated with PrP levels in both
experiments.
Methods
Cell lines and culture conditions
The conversion of murine ES cells into neuroepithelial
precursors (NPs) in adherent monoculture was per-
formed using the Sox1-GFP knock-in (46C) ES cell line
[23]. ES cells were initially plated on gelatin-coated
60 mm dishes at a density of 3 × 104 cells/cm2 in
GMEM (Invitrogen), supplemented with 10% fetal bo-
vine serum (ESC qualified FBS, Invitrogen), 2 ng/ml of
leukemia inhibitory factor (produced and purified ac-
cording to Mereau et al. [24]), 1× non-essential aminoa-
cids (Invitrogen), 2 mM glutamine (Invitrogen), 1%
penicillin/streptomycin (Invitrogen) and 1 mM 2-
mercaptoethanol (Sigma). For monoculture differenti-
ation, ES cells were dissociated with 0.5% trypsin and
plated onto polylysine/laminin (Sigma) coated 6-well
plates at a density of 2 × 104 cells/cm2 in serum-free
RHB-A medium (StemCell Science Inc.), supplemented
with 5 ng/ml of FGF2 (Peprotech). Medium was
renewed every two days. In an attempt to obtain a more
uniform NPs population, a transient selection for 48 h
with 0.5 mg/ml puromycin (the Sox1-GFP reporter is
linked to a puromycin resistance gene by an internal
ribosome entry site [23]) was performed after three pas-
sages, using accutase for gentle dissociation [25]. Fixed
cells were imaged with an Axio Imager Z2 ApoTome
microscope (Carl Zeiss). The mouse PK1 cells used
herein are a subline of neuroblastoma N2a cells that effi-
ciently propagates RML (Rocky Mountain Laboratory)
prions [26]. PrP knockdown cells derived from PK1 cells
[21] were also used in this study.
RNA extraction and quantitative real-time PCR
Total RNA was extracted using the Quick-RNA Mini-
Prep (Zymo Research), for up to 5 × 106 cells, with in-
column DNase I treatment (Promega), according to the
manufacturer’s protocol. Nucleic acid quantification
was performed using a Nanodrop spectrophotometer
(Thermo Fisher Scientific) and 1 μg of RNA was used
to synthesize first-strand cDNA with qScript cDNA
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SuperMix (Quanta Biosciences), according to the manu-
facturer’s instructions. The cDNA was diluted 10-fold and
2 μl were used in each gene-specific PCR reaction, per-
formed in triplicate. Quantitative real-time PCR (qPCR)
was carried out on a CFX96 detection system (Bio-Rad)
using SYBR Select Master Mix from CFX (Invitrogen).
The qPCR was performed using specific primer pairs for
the genes of interest (Additional file 1: Table S1), according
to the following conditions: initial step at 95 °C for 5 min
followed by 40 cycles at 95 °C for 1 s and 60 °C or 65 °C
for 35 s. Changes in expression of the target genes were
normalized to glyceraldehyde 3-phosphate dehydrogenase
(Gapdh). Triplicate samples of cells were collected at each
time point and qPCR was performed on the cDNA synthe-
tized from three separate RNA preparations. For each of
the three biological replicates, CT values of three technical
replicates were averaged and whenever CV (%) >1 the
values were tested with Grubbs test (graphpad.com/quick-
calcs/Grubbs1.cfm) for outlier detection. Data were
analysed using the ΔΔCT method (CT, Target – CT,
Gapdh)Time X – (CT, Target – CT, Gapdh)Time 0. Time X
corresponds to the days of cell differentiation and Time 0
to the undifferentiated ES cells. The fold changes based on
the 2-ΔΔCT calculation [27] were obtained from the ΔΔCT
averaged means of the biological replicates.
Flow cytometry
Cells were collected mechanically using cell scrapers,
centrifuged at 1200 rpm for 5 min and resuspended
in 4% FBS in PBS. Acquisition was performed in a
FACSCalibur cytometer (Becton Dickinson). Live cells
were gated based on forward and side scatters and
GFP fluorescence presented as stacked histograms.
Protein prefractionation with Triton X-114
Cells were resuspended in ice-cold PBS and then ex-
tracted by addition of 2% (v/v) Triton X-114 (Sigma-
Aldrich) followed by 15 min on ice. The mixture was
clarified by centrifugation, at 10000 g for 10 min at
4 °C, the supernatant transferred to a new tube and
warmed at 37 °C until it became cloudy. The solution
was then centrifuged at 1500 g for 10 min at room
temperature (RT) to separate into two protein-
containing phases due to aggregation of detergent mi-
celles [28]. The lower phase enriched in detergent
containing membrane associated proteins with an
amphiphilic nature was precipitated with acetone for
a minimum of 2 h at -20 °C. After centrifugation at
10000 g for 10 min at 4 °C, pellets were allowed to
dry and then resuspended in CHAPS buffer. The
protein samples were quantified by a Bradford micro-
plate assay (BioRad).
Western blotting
Protein samples (25 μg) were denatured with Laemmli
buffer and heated at 95 °C for 10 min. The separation
was performed by SDS-PAGE in 12.5% gels. Proteins
were then transferred onto low fluorescence PVDF
membranes (Thermo Fisher Scientific) by electroblotting
at 300 mA for 1 h. After blocking overnight in 5% milk/
TBS/0.05% Tween-20 (TBST), membranes were washed
and probed with primary monoclonal antibody (POM1,
Prionics; GRP78/HSP5, Thermo Fisher Scientific) in 1%
milk/TBST for 1 h at RT. After three washes with TBST,
membranes were probed with secondary antibody goat
anti-mouse IgG conjugated to AF488 (Invitrogen). Sub-
sequently, the membranes were thoroughly washed with
TBST and allowed to dry before fluorescence imaging
using a Typhoon Trio scanner (GE Healthcare). The
membranes were reprobed with anti β-actin antibody for
protein load verification, either directly conjugated to
AF647 (Santa Cruz) or indirectly using a goat anti-
mouse IgG conjugated to AF647 (Invitrogen).
Two-dimensional differential gel electrophoresis
Two-dimensional differential gel electrophoresis (2D-
DIGE) was performed in a mixture of protein samples,
labelled according to the CyDye minimal labelling
method (GE Healthcare). Cy2 was used for the internal
standard, composed of a balanced amount of each of the
samples, whereas Cy3 and Cy5 were used to label the
different samples, applying a dye swap to avoid biasing
of the results due to differential labelling. Labelled sam-
ples were pooled by three such that each pool contained
an equal ratio of proteins marked with Cy2, Cy3 and
Cy5. Finally, 5.4 μL of Destreak Reagent (GE Health-
care), 1% (v/v) of IPG buffer pH 3 − 11NL (GE
Healthcare) and CHAPS lysis buffer were added to reach
a final volume of 450 μl. Additionally to the analytical
gels, preparative gels with a total protein load between
400-500 μg were run for Coomassie blue staining
dedicated to spot picking.
The migration of the first dimension or isoelectric focus-
ing (IEF) was carried out using IPG strips pH 3 − 11NL,
24 cm (GE Healthcare), after overnight passive rehydra-
tion. The IEF was carried out on an Ettan IPGphor 3 IEF
unit (GE Healthcare) with the following parameters: (1)
gradient to 250 V for 1 h, (2) constant voltage of 250 V for
1 h, (3) gradient from 250 V to 1000 V for 2 h, (4) gradient
from 1000 V to 8000 V for 3 h and (5) constant voltage of
8000 V for 5 h 40 min. The temperature was set at 20 °C
and the current was limited to 75 μA/strip. After the first
dimension, strips were equilibrated in equilibration buffer
containing 75 mM Tris-HCl pH 8.8, 6 M urea, 30% (v/v)
glycerol, 2% (w/v) SDS complemented with 1% (w/v) DTT
(AppliChem) for 15 min and subsequently 15 min in
equilibration buffer complemented with 2.5% (w/v)
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iodoacetamide (GE Healthcare). Strips were rinsed in cath-
ode buffer, placed on top of the second dimension gels and
sealed with low-melt agarose (AppliChem). Cathode and
anode buffers were added in the electrophoresis tank
(Ettan DALT six, GE Healthcare) and the gels were run at
20 °C. The migration settings were: (1) 10 mA/strip for 1 h
and (2) 40 mA/strip until the sample reached the end of
the gel. The preparative gels dedicated to picking were
fixed in 50% (v/v) ethanol containing 2% (v/v) phosphoric
acid for a minimum of 2 h. Subsequently, gels were
washed three times for 20 min with ddH2O and left over-
night in an equilibration solution for coloration with 34%
(v/v) methanol, 17% (w/v) aluminium sulphate, 2% (v/v)
phosphoric acid and 3% (w/v) of Coomassie brilliant
blue G250 (Amresco).
Gels were scanned using a Typhoon Trio Variable
Mode Imager (GE Healthcare) at a resolution of 100 μm.
The gel images were analysed using the software Same-
Spots (TotalLab). Spot comparisons between the sam-
ples were carried out by calculating the ratio between
the average intensity of the conditions. When the aver-
age intensity of a spot measured in a differentiated sam-
ple exceeded the one measured in the ES sample, we
reported a protein fold change equal to the ratio r. In
the case where the spot intensity was lower than the one
measured in ES cells (when r < 1), we reported a fold
change equal to −1/r. Only significant absolute fold
changes superior to 1.5 for the first experiment or 2.0
for the second experiment (ANOVA, p-value ≤ 0.05)
were considered. Differentially abundant spots were
matched onto the high protein load gels and picked
from the latter for MS analysis.
Mass spectrometry analysis and protein identification
Digestion and MALDI spotting were carried out using an
Ettan spot handling workstation (GE Healthcare) or a
Janus liquid handling workstation (Perkin Elmer), in the
first and second experiment, respectively. In-gel tryptic di-
gestion protocols were the standard used in each proteo-
mics platform (CRP-Gabriel Lippmann, Luxembourg and
GIGA, Belgium). The MALDI peptide mass spectra were
acquired using either an AB SCIEX TOF/TOF 5800 (Ap-
plied Biosystems) or an UltrafleXtreme TOF/TOF (Bru-
ker). All spectra, MS and MS/MS, were submitted for
database dependent identification on the MASCOT server
using either NCBInr (143978 sequences) or Swissprot with
restricted taxonomy Mus musculus. The parameters used
for these searches were mass tolerance MS 100 ppm, mass
tolerance MS/MS 0.5 Da, fixed modifications cysteine car-
bamidomethylation and variable modifications methionine
oxidation, double oxidation of tryptophan and tryptophan
to kynurenine. Proteins were considered identified when
at least two peptides passed the MASCOT-calculated
threshold score (p < 0.05).
Bioinformatics analysis
The molecular interaction network for each set of
proteins differentially abundant in our analyses was
obtained by generating a comprehensive list of phys-
ical interactions gathered from five online databases:
StemCellNet [29], UniHI [30], STRING [31], Gene-
MANIA [32] and QIAGEN’s Ingenuity Pathway
Analysis [33]. The data retrieved from these sources
were formatted, filtered and merged using customized
Bash and R scripts. To build a high-confidence inter-
action data set, we selected only experimental data
(i.e. excluding computationally predicted interactions)
and direct interactions with our proteins of interest,
generating a final list containing 1993 physical inter-
actions for the first set of differentially abundant pro-
teins (Additional file 2: Figure S1). Building this
customized interaction data set was necessary to over-
come the minimal agreement between different
databases (Additional file 3: Figure S2). The network
connecting the differentially abundant proteins was
generated using Cytoscape version 3.3.0 [34]. A GO en-
richment analysis, using Mus musculus as reference, was
performed on both data sets for cellular component using
PANTHER [35] and the overrepresented categories con-
sidered significant at p < 0.05 after Bonferroni correction.
Additionally, a GO enrichment analysis was conducted for
the full interactome of the first data set, using Cytoscape
plugin BiNGO version 3.0.3 [36]. BiNGO analyses were
performed using custom updated GO and mouse GO an-
notation files (downloaded from the Gene Ontology Con-
sortium website), discarding the GO evidence codes ISS,
IEA, NAS and ND. The overrepresentation was consid-
ered significant at p < 0.05 after Bonferroni correction.
Results
Pluripotency and neural differentiation markers
expression in differentiating ES cells
Neural differentiation of the ES cell line 46C in ad-
herent monoculture was followed morphologically and
through expression of Sox1-GFP knock-in reporter
(Fig. 1). Sox1 is the earliest known specific marker of
neuroectoderm in the mouse embryo [23]. As previ-
ously reported, undifferentiated 46C ES cells do not
express Sox1-GFP and an increase in GFP fluores-
cence is observed during differentiation to NPs [37].
These values tend to be more variable on day 3, due
to differences on the onset of differentiation, and
reach a plateau from day 4 to day 6. Flow cytometry
analysis during ES cells differentiation to NPs showed
some heterogeneity in Sox1-GFP positive cells that
decline after day 6. The full transcriptome of neural
differentiation of 46C ES cells was previously charac-
terized [37] and the culture conditions were mim-
icked in our study, without splitting to avoid
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interfering with PrP expression on the membrane.
The qPCR results confirm neural differentiation of ES
cells showing significant downregulation of the stemness
markers Oct4 and Nanog during the process of neural
conversion (Fig. 2). Sox-1 levels increased on day 3 and
lowered from day 3 to days 6 and 9 corresponding
approximately to the flow cytometry data, although high
statistical significance was only attended at the latter time
point due to lower variability. Nestin widely used as
a neural stem/progenitor cell marker increased its
expression with statistical significance (Fig. 2 a-d).
Prion protein expression during the differentiation of ES
cells into NPs
The expression of PrP was evaluated both at the mRNA
level, by qPCR, and at the protein level, by western blot
(Fig. 3a and 3b). Levels of mRNA increased upon trigger
of differentiation with some large variation on days 6
and 9. The highest consistent levels were found at the
NPs stage. The expression of PrP was analysed by
western blot after Triton X-114 prefractionation. The
analysis showed bands between 25 and 37 kD,
corresponding to differentially glycosylated isoforms
Fig. 1 a) Phase contrast images during ES cells differentiation. For day 9 a differential interference contrast (DIC) image was chosen to highlight
axonal projections being formed particularly in the periphery of rosettes. b) Flow cytometry profile of Sox1-GFP activation for the same time
points of ES cells differentiation
Fig. 2 a-d) Quantitative mRNA expression of different markers during ES cells differentiation (0, 3, 6, 9 days). a) Oct4, b) Nanog, c) Sox1 and d)
Nestin. Pairwise t-tests were performed to calculate significant differences compared to ES cells (*p < 0.05, **p < 0.01, ***p < 0.001)
Macedo et al. BMC Genomics  (2017) 18:319 Page 5 of 13
(unglycosylated, monoglycosylated and its most abun-
dant diglycosylated form). The levels of PrP showed an
increasing trend along the time of differentiation, reach-
ing its highest in NPs as observed at mRNA. These re-
sults confirm that PrP levels are directly associated with
neuronal differentiation, hence playing a role both in
neurogenesis and in cellular differentiation [19].
Proteins differentially abundant during neural
differentiation of ES cells
Triton X-114 prefractionation was demonstrated to en-
able the selective enrichment of hydrophobic proteins
[28] and followed by 2D-PAGE remains a method of
choice for proteomic characterization of the membrane
protein subset [38]. In our study, we have decided for
this simple enrichment step that rendered the protein
yield suitable for quantitative 2D-DIGE. Subsequently,
the GO enrichment analysis for cellular component vali-
dated the use of this prefractionation step to enrich for
membrane-associated proteins. ES cells were allowed to
differentiate for 9 days and samples were collected from
three time points: ES cells, D6 and D9. The time
point D3 was excluded from sampling due to possible
differences on the onset of differentiation. Three con-
ditions with four biological replicates were selected
for a single run. The gel analysis, after manual valid-
ation of the spots with p < 0.05 (ANOVA), revealed
158 spots with significantly different abundance
(Fig. 4a). From these, we confidently picked 32 of
which 29 were successfully identified as corresponding
to 25 distinct proteins. These proteins are shown in
Table 1 with indication of the fold change during the
differentiation process, associated gene nomenclature,
theoretical molecular weight, pI and sequence cover-
age by tandem MS. A more complete table, including
the accession number ID and Mascot scores is avail-
able (Additional file 1: Table S2). From the 25 distinct
proteins identified as differentially abundant, 14 pro-
teins were shown to increase and 11 to decrease its
levels during the differentiation of ES cells. The pro-
tein identified as cellular retinoic acid-binding protein
I (CRABPI) had the highest increase of 13.7 fold
Fig. 3 a) Prion protein mRNA expression during ES cell differentiation. Pairwise t-tests were performed to calculate significant differences compared to
ES cells (*p < 0.05, **p < 0.01, ***p < 0.001). b) Western blot of PrP expression during ES cell differentiation; β–actin was used as loading control
Fig. 4 a) 2D-DIGE Cy2 reference gel comparing ES differentiating cells. b) 2D-DIGE Cy2 reference gel comparing PK1 and PK1-KD cells. Significant
differences were calculated by ANOVA (p < 0.05) and marked spots correspond to picked spots with ± 1.5 or 2.0 fold changes for a) and
b), respectively. Numbered spots correspond to the identified proteins. c) Western blot for detection of HSPA5 in ES compared to day 9 cells
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change and heat shock protein beta-1 (HSPB1) had
the highest decrease of 11.0 fold change. Figure 4c
shows a western blot corroborating the 2D-DIGE in-
crease in HSPA5, one of PrP direct interactors [39]
that highlights the importance of protein folding as
the biological process most significantly enriched con-
comitantly with changes in PrP expression (see dis-
cussion). Global gene expression profiling using
Affymetrix microarrays for the same cell line was pre-
viously published [37] and we compared our results
to their report using the same cut-off parameter of
± 1.5 fold change (Table 1). From the 14 proteins for
which the comparison was possible, 12 proteins were
in agreement with the previous results. The two ex-
ceptions showing contrary fold changes between
protein and mRNA levels were the mitochondrial
inner membrane protein (IMMT) and the phospho-
glycerate mutase 1 (PGAM1).
Proteins differentially abundant in neuroblastoma cells
expressing the prion protein and knockdown for the
prion protein
Quantitative 2D-DIGE was also performed for compari-
son between PK1 neuroblastoma cells expressing PrP
and PK1-KD which are knockdown for PrP, aiming at
gathering information about the effect of PrP ablation
on the membrane enriched proteome. The levels of PrP
in PK1-KD cells are almost undetectable by western blot
and immunocytochemistry [21, 40]. From a selection of
41 spots with significantly different abundance, 23 were
Table 1 Proteins differentially abundant during neural differentiation of ES cells. Fold change refers to increased levels (positive FC)
or decreased levels (negative FC) of protein content from ES to D6 and D9. Fold change ± 1.5 (ANOVA p < 0.05) was used as
threshold for protein identification
Spot # Protein [Mus musculus] Gene Mw(kDa) pI SC(%) FC Array*
297 Inner membrane protein, mitochondrial Immt 80.9 6.8 62 +1.8 ↓b
341 78 kDa glucose-regulated protein precursor Hspa5 72.5 5.1 45 +1.6 –
367 Far upstream element-binding protein 1 Fubp1 67.3 7.2 61 +2.1 ↑a
370 Heat shock cognate 71 kDa protein Hspa8 42.4 6.7 62 −1.6 ↓a
380; 383 Lamin-B1c Lmnb1 67.0 5.1 56 +2.4; +2.8 –
403 Succinate dehydrogenase [ubiquinone] flavoprotein
subunit, mitochondrial
Sdha 73.6 7.1 53 +2.1 –
503; 511 60 kDa heat shock protein, mitochondrialc Hspd1 59.6 8.1 44 −1.8; − 2.0 –
545 Protein disulfide-isomerase A3 Pdia3 57.1 5.9 49 +1.9 –
555 Protein disulfide-isomerase P4hb/Pdia1 57.4 4.8 45 +1.6 –
621 Heterogeneous nuclear ribonucleoprotein H Hnrph1 47.9 6.1 46 +1.9 ↑a
624 ATP synthase, mitochondrial F1 complex, alpha subunit Atp5a1 54.9 9.4 14 +1.9 –
669 Enolase 1B Eno1 47.5 6.4 62 −1.8 ↓a
693 Reticulocalbin-2 Rcn2 37.3 4.3 38 +2.4 ↑a
751 Actin, cytoplasmic 1 Actb 42.1 5.3 45 −1.7 –
808 Mitochondrial import receptor subunit TOM40 Tomm40 38.3 7.6 58 −1.9 ↓a
851 mCG49244 C9orf156 21.8 5.7 76 +2.6 –
963 Glyceraldehyde-3-phosphate dehydrogenase Gapdh 36.1 8.4 15 −2.0 –
1041 Voltage-dependent anion-selective channel protein 2 Vdac2 32.3 7.4 65 −1.6 ↓a
1050 YL2 protein C1qbp 23.8 4.4 13 −2.6 ↓a
1134 Phosphoglycerate mutase 1 Pgam1 28.9 6.7 77 +1.8 ↓b
1201 Heat shock protein beta-1 Hspb1 23.1 6.1 26 −11.0 ↓a
1209 Glutathione S-transferase A4 Gsta4 25.6 6.8 49 −3.4 ↓a
1450 Cytochrome b-5, type B Cyb5b 13.3 5.7 41 −1.9 –
1545 Fatty acid binding protein 7, brain Fabp7 15.2 5.1 87 +7.6 ↑a
1557 Cellular retinoic acid-binding protein I CrabpI 15.6 5.3 92 +13.7 ↑a
SC sequence coverage, FC fold change
*Microarray trend in expression comparing ES to D8 is shown for the available protein-coding genes [37]; data from probe sets giving conflicting results for the
same gene and fold changes below the cut-off of 1.5 were excluded. asame trend; bopposite trend; cproteins identified in two different spots
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picked resulting in the identification of 8 spots and 6
distinct proteins (Fig. 4b and Table 2). From the 6
distinct proteins identified, 4 were higher and 2 lower
in PK1-KD when compared to PK1 cells. Comparing
the two sets of identified proteins in ES cells and
PK1 cells, succinate dehydrogenase complex flavopro-
tein subunit A (SDHA) was detected as common pro-
tein, whilst the alpha subunit of mitochondrial ATP
synthase (ATP5A1) was identified in the first set and
the beta subunit (ATP5B) was identified in the sec-
ond set. Interestingly, SDHA increased during neural
differentiation concomitantly with increased levels of
PrP and was found to be lower in cells not expressing
the latter. For PK1 cells, SDHA was identified in
three different spots that were decreased with similar
fold change in PK1-KD cells (-2.5 ± 0.5). ATP5A1 in-
creased upon neural differentiation, concomitantly
with the levels of PrP, but ATP5B also increased sig-
nificantly in PK1-KD cells. PK1 cells, which are
highly efficient in the replication of RML prions [26],
were infected as previously described [40] and a 2D-
DIGE experiment comparing non-infected and in-
fected cells was carried out. This experiment gave no
significant differential abundance of proteins (data not
shown), which was not surprising since no transcrip-
tional changes seem to be induced by prion infection
of neural cell lines [41]. Transcriptome changes seem
to occur between susceptible and resistant PK1 sub-
clones [42] but were not induced by infection [41].
GO enrichment analyses and interactome of differentially
abundant proteins
To validate the prefractionation technique and its
ability to successfully enrich the sample with
membrane-associated proteins, we conducted a GO
enrichment analysis for cellular component. Figure 5a
shows the results for the first experimental set. This
analysis revealed that the identified proteins were
mainly associated with the membrane of intracellular
organelles, namely the mitochondria. “Focal adhesion”
was also significantly enriched in the first set regard-
ing neural commitment. Interestingly, both sets of
identified proteins were enriched in “myelin sheath”
associated proteins (n = 12, p < 0.001 in the first set
and n = 3, p < 0.02 in the second set). The sets of dif-
ferentially abundant proteins were too small to show
a representative enrichment in GO molecular func-
tion or GO biological process categories. Accordingly,
we proceeded with generating a customized interac-
tome for the 25 differentially abundant proteins dur-
ing differentiation, plus PrP, selecting only physical
interactions which have been experimentally corrobo-
rated (Additional file 2: Figure S1). This approach
aimed at gaining better insight into the relevant func-
tions and biological processes present in the full in-
teractome of our identified proteins (Fig. 5b). The
most represented and prominent molecular functions
found were “enzyme binding” and “transcription fac-
tor binding”. “Anatomical structure development” and
“cell proliferation” were the most represented bio-
logical processes while “protein folding” and “kinase
activity” were more significantly enriched (vide p-values).
For the set of differentially abundant proteins alone, both
“protein folding” and “ATPase activity” were also signifi-
cantly enriched (Fig. 5b, GO terms in blue). According to
our analysis, the physical interactions between the pro-
teins differentially abundant upon neural commitment,
including PrP, are shown in Fig. 6. From the 25 identified,
18 proteins had at least one interactor whilst 7 of them
were orphan nodes. The main interactors were HSPs,
namely HSPD1 (n = 10), HSPA8 (n = 9) and HSPA5 (n =
7). For PrP, four known interactors were identified:
HSPD1, HSPA5, P4HB/PDIA1 and LMNB1 [39, 43, 44].
Other PrP interactors not reported in the resorted data-
bases are PDIA3, ATP5A1, GAPDH and β-actin [45–48].
For the second set of differentially abundant proteins be-
tween PK1 and PK1-KD cells (Table 2), no interactors
with PrP were found and a single experimental interaction
between ATP5B and acyl-protein thioesterase 1 (LYPLA1)
was reported in all queried databases.
Table 2 Proteins differentially abundant in PK1 neuroblastoma cells knockdown for the prion protein. Four proteins showed
increased levels (positive FC) and two decreased levels (negative FC) in knockdown cells. Fold change ± 2 (ANOVA p < 0.05) was
used as threshold for protein identification
Spot # Protein [Mus musculus] Gene Mw(kDa) pI SC(%) FC
268; 272; 276 Succinate dehydrogenase [ubiquinone] flavoprotein
subunit, mitochondrialc
Sdha 73.6 7.3 16 −2.1; − 2.3; − 3.0
278 Structural maintenance of chromosomes protein 2 Smc2 13.5 9.1 19 +4.4
279 T-complex protein 1 subunit theta Cct8 60.1 5.3 31 +4.7
316 ATP synthase subunit beta, mitochondrial Atpb 56.3 5.1 17 +6.3
522 Elongation factor Tu, mitochondrial Tufm 49.9 7.9 14 −2.3
938 Acyl-protein thioesterase 1 Lypla1 25.0 6.2 10 +2.0
SC sequence coverage, FC fold change
cSDHA identified in three different spots with similar fold differences
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Discussion
Several functions have been assigned to PrP spanning
from neurotransmission, olfaction, proliferation and dif-
ferentiation of neural precursors, myelin maintenance,
copper and zinc transport, calcium homeostasis as well
as neuroprotective activities against several toxic insults
such as oxidative and excitotoxic damage [13]. How does
this protein gather so many functions? Does the answer
lie in its ability to function as a pleiotropic protein
through the interaction with multiple different mem-
brane proteins? Two cellular systems, combined with a
quantitative membrane-enriched proteomic analysis,
were used in this study to identify proteins possibly
related to the function of PrP. Firstly, ES cells were
induced to differentiate into NPs as PrP has been
proposed to participate in transmembrane signalling
processes associated with neuronal differentiation during
early embryogenesis and in adult neurogenesis [19, 49].
Recently, it was shown that silencing PrP suppressed
differentiation of human ES cells towards ectodermal
lineages indicating that expression of PrP guides differ-
entiation rather than resulting from differentiation [20].
Fig. 5 a) GO enrichment for cellular component, according to PANTHER analysis, for the differentially abundant proteins during neural
differentiation of ES cells. The results are represented as –log p-value (left axis) and fold enrichment (right axis) for each category using Mus
musculus as reference. The GO terms were clustered based on similarity. b) GO slim enrichment terms related to molecular function and
biological process categories, calculated with BiNGO on Cytoscape, using the full interactome data set. Circle size is proportional to the frequency
of the GO term, while colour indicates the –log p-value (orange for higher, yellow for lower). GO terms in blue represent the ones also found
significant when testing only the differentially abundant proteins
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Indeed, levels of PrP increased during the differentiation
of ES cells and were higher at the latest stage analysed
(Fig. 3). Secondly, the PK1 neuroblastoma cell line that
efficiently propagates RML prions [26] and PK1-KD, its
knockdown counterpart for PrP [21], were analysed for
membrane-enriched proteome changes. From the set of
differentially abundant proteins upon neural differenti-
ation, 25 proteins were identified (fold change ≥ ± 1.5)
where 14 were shown to increase and 11 to decrease its
expression levels (Table 1). The highest fold differences
were the increases in proteins belonging to the intracel-
lular lipid binding proteins superfamily, FABP7 and
CRABPI, involved in binding intracellular hydrophobic
ligands and trafficking them throughout cellular com-
partments [50]. Knockdown of PrP has resulted in the
identification of 6 distinct proteins differentially abun-
dant (fold change ≥ ± 2), where 4 showed higher and 2
lower expression levels (Table 2).
The quantitative results obtained with 2D-DIGE were
further explored using bioinformatics tools to build pro-
tein networks and gain indications about possible path-
ways involved in neural differentiation and in the role of
PrP. GO enrichment analysis for the cellular component
category carried out for the 25 differentially abundant
proteins upon neural commitment revealed an enrich-
ment for “myelin sheath”, “organelle membrane” and
“focal adhesion” associated proteins, reflecting not only
the neural features of differentiation but also the
prefractionation step used to select the membrane pro-
tein subset (Fig. 5a). Enrichment in proteins involved in
“focal adhesion” might be consistent with a role of PrP
in the modulation of cell adhesion and stability of adhe-
rens cell junctions during embryonic development [51].
The enrichment analysis performed for the GO molecu-
lar function and GO biological process was done for the
customized interactome, built for the 25 differentially
abundant proteins in order to strengthen the functional
enrichment analysis. “Enzyme binding” appeared as the
most prominent molecular function and “protein fold-
ing” and “kinase activity” as the most significantly
enriched biological processes associated to the neural
differentiation of ES cells (Fig. 5b). Interestingly, using
the set of differentially abundant proteins alone, “protein
folding” and “ATPase activity” were also significantly
enriched biological processes. A previous proteomic
study [52] also reported "protein folding" as the bio-
logical process associated to changes in the expression
of PrP. Moreover, a recent shotgun proteomic study
using CRISPR-Cas9-based knockout of PrP in NMuMG
cells found that “cell adhesion”, “epithelial cell differenti-
ation” and “response to inorganic substances” were bio-
logical processes significantly enriched for proteins with
altered levels, possibly reflecting the ability of this cell
line to undergo epithelial-to-mesenchymal transitions
[53]. The lack of overlap between the proteins identified
in different proteomic studies could be attributed to cell
type-specific effects of PrP pleiotropy, as previously re-
ported [52, 53].
The interactome for the specific set of proteins differ-
entially abundant during neural differentiation of ES
cells was obtained to gather insight into putative func-
tional links between PrP and other relevant proteins.
Our interactome revealed four interactors with the PrP
(HSPD1, HSPA5, P4BH/PDIA1 and LMNB1, see Fig. 6).
Although, not reported in the resorted databases, PDIA3
was demonstrated to interact with PrP in N2a cells by
co-immunoprecipitation [45], β-actin was found to inter-
act with PrP in junctional domains of enterocytes [46]
and two other members of the interactome (ATP5A1
and GAPDH) were found to co-purify with a myc tagged
PrP from transgenic mouse brains [47]. From these pos-
sible interactors with PrP, six (HSPD1, HSPA5, PDIA3,
ATP5A1, GAPDH and β-actin) are annotated as “myelin
sheath” associated proteins. Several of the proteins co-
purified with myc tagged PrP also belonged to the group
of myelin-associated proteins [47], suggesting that en-
richment in myelin-associated proteins revealed by our
GO analysis might not be due merely to a neural signa-
ture of the cell lines. Some interactors might even be
possible candidates for mediation of PrP myelinotrophic
effects [54]. Additionally, our results showed that differ-
entiation is accompanied with change in expression
Fig. 6 Physical interactions between the differentially abundant
proteins during differentiation of ES cells. Proteins with increased
expression (n= 9) are represented by green nodes and with decreased
expression (n= 9) by red nodes, while PrP (here designated with the
official queried symbol PRNP) is shown in grey. Orphan protein nodes
(n = 7) are not shown
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patterns of HSPs (Fig. 5b and Table 1). A subpopulation
of HSPs was shown to associate with membranes and to
play a role in membrane quality control [55]. It is em-
phasized that different HSPs have been found to associ-
ate, to a variable extent, with detergent-resistant
microdomains (“rafts”) and this association can be mod-
ulated by stress. The membrane microdomain-associated
HSPs can evidently participate in the orchestration and
activity of distinct raft-associated signalling platforms
[56–58]. We have identified four HSPs (HSPA5, HSPA8,
HSPD1, HSPB1), mostly with decreased expression dur-
ing the cells’ differentiation process, with the exception
of the PrP interactor HSPA5. This chaperone, also
known as 78 kDa glucose regulated protein (GRP78 or
BiP), is the best studied chaperone to date with regard
to protein folding disorders of the brain due to its cen-
tral role in the activation of the unfolded protein re-
sponse (UPR) [59]. Mice deficient in HSPA5, specifically
in Purkinje cells, show activation of the UPR, apoptotic
cell death and cerebellar atrophy, ultimately leading to
death [60], emphasizing the importance of HSPA5 neur-
onal expression. In patients with sporadic CJD and in
mice with scrapie, an increase in the levels of molecular
chaperones such as GRP58, HSPA5 and HSP70 has been
reported [61–63].
Two PDIs, PDIA1/P4HB and PDIA3 also known as
GRP58, increased concomitantly with the expression of
PrP upon neural differentiation and were previously re-
ported to interact with the latter. Increased expression
of PDIA1 following stable PrP overexpression in neur-
onal SH-SY5Y cells was reported in another proteomic
study [52]. PDIA3 was also shown to be active in the
plasma membrane, in which it is located in lipid rafts
and binds to N-glycosylated proteins [64]. Both PDIs
can act as chaperones and catalyze thiol/disulfide ex-
change, which may generate one hydrogen peroxide
molecule per each disulfide bond formed in client pro-
teins [65]. In line with this, PrP is an N-glycosylated pro-
tein with one intramolecular disulfide bridge mainly
located in lipid rafts [66]. Recently, it was shown that
PDIA3 is highly expressed in the brain of sporadic and
infectious forms of prion diseases and controls the mat-
uration and total levels of PrP [67].
SDHA and two different ATP synthase subunits were
identified in both proteomic experiments performed, but
only SDHA showed a similar abundance trend as PrP,
i.e., increased abundance upon neural differentiation and
decreased abundance in PK1-KD cells. SDHA is a key
enzyme to attenuate the generation of reactive oxygen
species associated with the aerobic energy metabolism in
the mitochondria [22]. PDIA3, PDIA1 and SDHA are all
players involved in the redox homeostasis of cells. The
increased abundance observed for these three proteins
plus PrP may well be related to an ubiquitous role of
PrP in cell-redox homeostasis, where it may act as a
sensor for oxidative stress [68–71]. PrP expression
was previously shown to increase under oxidative
stress [69, 72, 73] and neurodegeneration mediated by
PrP is accompanied by a burst of reactive oxygen
species and suppressed by antioxidants [68].
Conclusions
Two cellular systems, where the expression of PrP changes
very significantly, were used to identify proteins and GO
categories possibly related to the function of PrP. Firstly,
ES cells were induced to differentiate into NPs, process
accompanied by a significant increase in the expression of
PrP. Secondly, neuroblastoma PK1 cells were compared to
its knockdown counterpart. From the set of differentially
abundant proteins, the main following conclusions were
extracted: (i) “protein folding” was the most significant
enriched biological process occurring with changes in the
expression of the prion protein in the first cell model used
in this study, (ii) interactors with PrP identified in our
study are annotated mostly as “myelin sheat” associated
proteins and therefore may mediate a myelinotrophic ef-
fect of PrP [54], (iii) succinate dehydrogenase, a key en-
zyme to attenuate the generation of reactive oxygen
species which is associated with the aerobic energy metab-
olism, showed a similar abundance trend as PrP in both
cell systems and (iv) protein disulfide isomerases, a class
of enzymes involved in cell-redox homeostasis [65, 74],
previously reported as PrP interactors [45, 67], were also
identified in our study as differentially abundant. Overall,
our study shows that PrP expression occurs concomitantly
with changes in chaperone activity and cell-redox homeo-
stasis, emphasizing the functional link between these cel-
lular processes and PrP.
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